Trial Profile

Effect of Liraglutide on Fatty Liver Content Evaluated by Proton-spectroscopy (1H-spectroscopy) and Lipoprotein Kinetic, in Patients With Type 2 Diabetes

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 26 Feb 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Liraglutide (Primary)
Indications Dyslipidaemias; Type 2 diabetes mellitus
Focus Therapeutic Use
Acronyms LIRA-NAFLD/LIP

Most Recent Events

25 Sep 2020 Results of an in vivo kinetic study presented at the 56th Annual Meeting of the European Association for the Study of Diabetes
12 Oct 2016 Results (n=80) assessing effect of liraglutide therapy on liver fat content published in the Journal of Clinical Endocrinology and Metabolism
16 Sep 2016 Results of invivo kinetic study presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com